Efficacy and safety evaluation of Azvudine in the prospective treatment of COVID-19 based on four phase III clinical trials

Overview of attention for article published in Frontiers in Pharmacology, August 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 104 X posts from 97 X users, with an upper bound of 263,923 followers.

RT @dlingenfelter: Azvudine has dual-target effects against HIV-1 and SARS-CoV-2 infections. The polymerase inhibitor reduced viral nuclei…

RT @dlingenfelter: Azvudine has dual-target effects against HIV-1 and SARS-CoV-2 infections. The polymerase inhibitor reduced viral nuclei…

RT @dbdugger: China repurposed while we burn up CD4 cells, brains, livers, and kidneys. Telling folks they live with ME until they develop…

@meowmix505 I’m not convinced there is enough there on azvudine.

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 100 additional X posts.